Preparation and characterization of quercetin and rutin cyclodextrin inclusion complexes

Drug Development and Industrial Pharmacy

Volumn 33, Issue 3, 2007, Pages 245-253

  Sri, K Vijaya ^a   Kondaiah, A ^a   Ratna, J Vijaya ^a   Annapurna, A ^a  

^a ANDHRA UNIVERSITY   (India)

Author keywords

CD; Dissolution; Phase solubility; Physicochemical characterization; Quercetin; Rutin

Indexed keywords

BETA CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; HYDROXYLPROPYL BETA CYCLODEXTRIN; QUERCETIN; RUTOSIDE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG SOLUBILITY; EVAPORATION; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; X RAY POWDER DIFFRACTION;

CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; QUERCETIN; RUTIN; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 34247499876     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040601150195     Document Type: Article

References (24)

1. Alan L. & Miller, N. D. (1996). Antioxidants: Structure function and clinical usage. Alternative Medicine Review, 1(2), 103-111.
2. Annapurna, A., Krishna, K. M., Gopal, G. S., Chalam, S. G. R., Madan, K., Kumar, V. K., & Prakash, G. J. (2005). Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocininduced diabetic rats. Can. J. Physiol. Pharmacol., 3(4), 343-355.
3. Bronner, C. & Landry, Y. (1985). Kinetics of inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Actions, 16, 147-151.
4. Buchi, N. N., Chowdary, K. P. R., Murthy, K. V. R., Hayman, A. R., & Becket, G. (2003). Physicochemical characterization and dissolution properties of nimesulide-binary systems. AAPS Pharm. Sci. Tech., 4(1), 1-11.
5. Calabro, M. L., Tommasini, S., Donato, P., Stancanelli, R., Raneri, D., Catania, S., Costa, C., Villari, V., Ficarra, P., & Ficcara, R. (2005). The rutin/β-CD interactions in fully aqueuous solution: spectroscopic studies and biological assays. J. Pharm. Biomed. Anal., 36(5), 1019-1018.
6. Challa, R., Ahuja, A., Ali, J., & Khar, R. K. (2005). Cyclodextrins in drug delivery: An update review. AAPS Pharm. Sci. Tech., 6(2), 329-357.
7. Degroot, H. & Rauen, U. (1998). Tissue injury by reactive oxygen species and the protective effects of flavonoiods. Fundam. Clin. Pharmacol., 12, 249-255.
8. Haiyun, D., Jianbin, C., Zhang, G. M., Shaomin, S., & Jinhao, P. (2003). Preparation and spectral investigation on inclusion complex of cyclodextrin with rutin. Spectrochimica Acta Part A Mol Biomol Spectrosc., A59, 3421-3429.
9. Hertog, M. G., Feskens, E. J., Hollman, P. C. H., Katan, M. B, & Kromhout, D. (1993). Dietary antioxidant flavonoids and risks of coronary heart disease: the zutphen elderly study. Lancet, 342, 1007-1011.
10. Hertog, M. G. L., Hollman, P. C. H., Katan, M. B., & Kromhout, D. (1993). In take of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr. Cancer., 20, 21-29.
11. Higuchi, T. & Connors, K. A. (1965). Phase solubility techniques In Reilly, C. N. (Ed.) Advances in Analytical Chemistry Instrumentation, Vol. 4; Interscience: New York, pp. 117-212.
12. Hollman, P. C. H., van Trijp, J. M., Buysman, M. N., van der Gaag, M. S., Mengelers, M. J., de Vries, J. H., Katan, M. B. (1997). Relative bioavail-ability of the antioxidant flavonoid quercetin from various foods in man. FEBS Letters, 418, 152-156.
13. Kaul, T. N., Middleton, E. Jr., & Ogra, P. L. (1985). Antiviral effect of flavonoids on human viruses. J. Med. Virol., 15, 71-79.
14. Khan, K. A. (1975). The concept of dissolution efficiency. J. Pharm Pharmacol., 27, 48-49.
15. Liu, L. & Zhu, S. (2006). Preparation and characterization of inclusion complexes of prazosin hydrochloride with β-CD and HP-β-CD. J. Pharm. Biomed. Anal., 40, 122-127.
16. Ljungman, A. G., Tagesson, C., & Lindahl, M. (1996). Endotoxin stimulates the expression of group II PLA2 in rat lung in vivo and in isolated perfused lungs. Am. J. Physiol., 5(Pt 1), L 752-760.
17. Loftsson, T. & Brewster, M. E. (1996). Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci., 85(10), 1017-1025.
18. Monograph on Quercetin. (1998). Alternative Medicine Review, 3(2), 140-143.
19. Pralhad, T. & Rajendrakumar, K. (2004). Study of freeze-dried quercetin-CD binary systems by DSC FT-IR, X-RD and SEM analysis. J. Pharm. Biomed Anal, 34, 333-339.
20. Rajewski, R. A. & Stella, V. J. (1996). Pharmaceutical applications of Cyclodextrins 2. In vivo drug delivery. J. Pharm. Sci., 85(11), 1142-1168.
21. Read, M. A. (1995). Flavonoids: Naturally occurring anti-inflammatory agents. American Journal of Pathology, 147(2), 235-237.
22. Stella, V. J. & Rajewski, R. A. (1997). Cyclodextrins: Their future in drug formulation and delivery. Pharm. Res., 14, 556-567.
23. Xilang Guo, Yang Yu, Zhai Guoyan, Zhang Guomei, Chao Jianbin, & Shuang Shaomin. (2003). Study on inclusion interaction of piroxicam with β-cyclodextrin derivatives. Spectrochim Acta A Mol. Biomol. Spectrosc., 59(14), 3379-3386.
24. Ying Zheng, Haworth, I. S., Zhong Zuo, Chow, M. S. S., Chow, A. H. L. (2005). Physicochemical and structural characterization of quercetin-β- cyclodextrin complexes. J. Pharm. Sci., 94(5), 1079-1086.